[Occlusive treatment of atrophic and erosive oral lichen planus with Clobetasol Propionate 0.05% ointment (Dermovat)].

The treatment of eight patients with histologically verified atrophic or erosive lichen planus are reported. The lesions of WHO-diagnosis code 697.02 were subdivided into three classes: atrophic, minor erosive and major erosive. Clobetasol Propionate ointment was placed in the buccal mucosa under an occlusive DuodermR dressing. Healing with striation was obtained in all of those lesions classified as atrophic or minor erosive, while major erosive lesions showed improvement, but persisted.
AuthorsB Roed-Petersen, J Roed-Petersen
JournalTandlaegernes nye tidsskrift (Tandlaegernes Tidsskr) Issue 1 Pg. 4-7 (Jan 1992) ISSN: 0901-9898 [Print] Denmark
Vernacular TitleOkklusive behandling af atrofisk og erosiv oral lichen planus med Clobetasolpropionat 0.05% (Dermovat).
PMID1449736 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Clobetasol
  • Aged
  • Clobetasol (therapeutic use)
  • Female
  • Humans
  • Lichen Planus (drug therapy)
  • Male
  • Middle Aged
  • Mouth Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: